Not Signed In - FlowCardia, Inc. Announces 510(k) Clearance For The CROSSER(TM) 14 Chronic Total Occlusion Recanalization System
Wed, 24 Jan 2007 08:00 AM EST
... FlowCardia, Inc., a medical device company developing endovascular devices for coronary and peripheral chronic total occlusion (CTO) recanalization, announced FDA 510(k) clearance of the CROSSER(TM) 14 CTO Recanalization System. The CROSSER 14 is designed to facilitate the placement of guidewires beyond CTOs in coronary arteries. [click link for full article] ...
Related Topics
- Creatinine Clearance
- Immune System
- Digestive System
- Endocrine System
- Total Protein
- Health System
- Creatinine
- Coronary Occlusion
- Chronic Fatigue Syndrome
- Chronic Pain
- Pain - Chronic
- Chronic Diseases
- Retinal vein occlusion
- Retinal artery occlusion
- Acute arterial occlusion - kidney
- Leukemia, Chronic Lymphocytic
- Chronic Lymphocytic Leukemia
- Hip Replacement
- Chronic Obstructive Pulmonary Disease
- Hysterectomy
email this page
print this page
bookmark this page
feedback on this page
